Rituximab Protects Insulin Producing Cells in Diabetes (CME/CE)
Patients with new-onset type 1 diabetes were modestly better able to retain beta cell function after treatment with the B-cell depleting agent rituximab (Rituxan), researchers said.
source : www.medpagetoday.com
Related News:
- AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
- AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
- AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
- HRT Linked to Asthma Risk (CME/CE)
- AM: Facet Graft Quells Refractory Back Pain (CME/CE)
- AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
- AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
- AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
- AM: Help for Pain and Mood in Fibromyalgia (CME/CE)
- Older Women with Gout at Risk of MI (CME/CE)
Details :
Submited at Wednesday, November 25th, 2009 at 7:01 pm on Cardiology by chuck
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















